Sept 26 (Reuters) - EMA:

* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADDITIONAL ADAPTED VERSION OF SPIKEVAX: 26/09/2022 Further company coverage: